Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Current Deferred Revenue (2023 - 2025)

Vsee Health filings provide 3 years of Current Deferred Revenue readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 217.0% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 217.0% increase, with the full-year FY2025 number at $1.3 million, up 217.0% from a year prior.
  • Current Deferred Revenue hit $1.3 million in Q4 2025 for Vsee Health, up from $1.2 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.3 million in Q4 2025 to a low of $87500.0 in Q2 2023.
  • Median Current Deferred Revenue over the past 3 years was $896083.5 (2023), compared with a mean of $852956.8.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 53.71% in 2024 and later soared 217.0% in 2025.
  • Vsee Health's Current Deferred Revenue stood at $902524.0 in 2023, then plummeted by 53.71% to $417815.0 in 2024, then soared by 217.0% to $1.3 million in 2025.
  • The last three reported values for Current Deferred Revenue were $1.3 million (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.